Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “MENINGOCOCCAL INFECTION”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00661557
What this trial is testing

Comparison of GSK134612 in Subjects Previously Vaccinated Against Meningococcal Disease Versus Non-vaccinated Subjects

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 271
Testing effectiveness (Phase 2)Study completedNCT02285777
What this trial is testing

Assessing the Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents

Who this might be right for
Meningococcal Disease
GlaxoSmithKline 189
Testing effectiveness (Phase 2)Study completedNCT04886154
What this trial is testing

A Study on the Safety, Effectiveness and Immune Response of Meningococcal Combined ABCWY Vaccine in Healthy Adolescents and Adults

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 1,440
Large-scale testing (Phase 3)Study completedNCT00443846
What this trial is testing

RotaTeq® and Meningococcus C Vaccine in Healthy Infants (V260-016)

Who this might be right for
Meningitis, MeningococcalRotavirus Infections
Merck Sharp & Dohme LLC 247
Post-approval studies (Phase 4)Study completedNCT01659996
What this trial is testing

Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age

Who this might be right for
MeningitisMeningococcal InfectionDiphtheria+3 more
Sanofi Pasteur, a Sanofi Company 1,394
Large-scale testing (Phase 3)Looking for participantsNCT07710872
What this trial is testing

Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Infants and Toddlers in China

Who this might be right for
Meningococcal InfectionHealthy Volunteers
Sanofi 4,568
Testing effectiveness (Phase 2)Study completedNCT00126984
What this trial is testing

Study in Children to Evaluate the Immunogenicity and Safety of 4 Formulations of GSK Bio MenACWY-TT Conjugate Vaccine

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 508
Post-approval studies (Phase 4)Study completedNCT03125616
What this trial is testing

Babies Born Early Antibody Response to Men B Vaccination: BEAR Men B

Who this might be right for
PrematurityVaccinationMeningococcal Disease
St George's, University of London 136
Post-approval studies (Phase 4)Study completedNCT00454987
What this trial is testing

Study of Long-term Antibody Persistence After a Booster Dose of Menitorix Vaccine

Who this might be right for
Haemophilus Influenzae Type bNeisseria MeningitidisNeisseria Meningitidis-Haemophilus Influenzae Type b Vaccine
GlaxoSmithKline 288
Large-scale testing (Phase 3)Study completedNCT00291343
What this trial is testing

Immune Response & Safety of GSK Biologicals' Mencevax™ ACWY in Subjects Primed in the DTPW-HBV=HIB-MENAC-TT-011 Study

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 296
Post-approval studies (Phase 4)Study completedNCT00227422
What this trial is testing

Assess the Non-inferiority of GSK Biologicals' Mencevax™ ACWY (Manufactured by a New Process) vs Mencevax™ ACWY (the Already Existing Vaccine in the Market) When Given as a Single Dose to Subjects Aged 2-30 Yrs

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 324
Large-scale testing (Phase 3)Study completedNCT03621670
What this trial is testing

Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 1,196
Early research (Phase 1)Study completedNCT04714229
What this trial is testing

Safety and Immunogenicity of Meningococcal Conjugate Vaccine in Healthy Adults Aged 19 to 55 Years Old

Who this might be right for
Infection, Meningococcal
EuBiologics Co.,Ltd 60
Post-approval studies (Phase 4)UnknownNCT03682939
What this trial is testing

Evaluation of Safety and Immunogenicity of Meningococcal B and Meningococcal ACWY Vaccine in at Risk Population

Who this might be right for
HivMeningitis, MeningococcalHIV Infections
St George's, University of London 55
Large-scale testing (Phase 3)Study completedNCT01962207
What this trial is testing

The Long-term Antibody Persistence of MenACWY-TT Vaccine (PF-06866681) Versus Meningitec(Registered) or Mencevax(Registered) ACWY in Healthy Adolescents and Adults and a Booster Dose of MenACWY-TT Administered 10 Years Post Primary Vaccination

Who this might be right for
Infections, Meningococcal
Pfizer 243
Post-approval studies (Phase 4)Study completedNCT00777257
What this trial is testing

Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine

Who this might be right for
MeningitisMeningococcemiaPertussis+2 more
Sanofi Pasteur, a Sanofi Company 1,345
Post-approval studies (Phase 4)Study completedNCT03493919
What this trial is testing

A Sourcing Study to Collect Human Blood Samples From Healthy Adults

Who this might be right for
Meningitis, Meningococcal
GlaxoSmithKline 1,021
Testing effectiveness (Phase 2)Study completedNCT00454909
What this trial is testing

Immunogenicity and Safety of Meningococcal Vaccine GSK134612 vs. Menactra® in Healthy Adolescent/Adults Aged 10-25 Years.

Who this might be right for
Infections, Meningococcal
GlaxoSmithKline 873
Large-scale testing (Phase 3)Study completedNCT03205371
What this trial is testing

Immunogenicity and Safety of a Meningococcal Conjugate Vaccine Given Concomitantly With Other Vaccines in Toddlers

Who this might be right for
Meningitis, Meningococcal
Sanofi Pasteur, a Sanofi Company 1,183
Large-scale testing (Phase 3)Study completedNCT01900899
What this trial is testing

Persistence of Antibodies After Meningococcal Vaccine PF-06866681 in Healthy Children

Who this might be right for
Infections, Meningococcal
Pfizer 184
Next Page